In this study, we developed alpaca-derived, small sized single domain antibodies (sdAbs, 12-15 kDa), cross-reactive for mouse and human AXL protein, and evaluated their potential in a diagnostic and therapeutic context in AML. Here, AXL is linked to acute myeloid leukemia.